The track-and-trace systems provider expands its life sciences portfolio by integrating the high-speed, adaptable ETF-300 ...

In the first part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

The move bolsters the CDMO’s commitment to cell and gene therapy by incorporating advanced manufacturing and fill-finish ...

Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement ...

Fran Gregory, VP, emerging therapies, Cardinal Health, emphasizes the need for long-term outcomes tracking and robust health economic modeling to demonstrate the sustained value of advanced therapies ...

Kapil Raina, MD, Principal of Market Access at Herspiegel Consulting, talks about disconnects in the industry, how patients have easier access to healthcare information, and the exciting future of ...

Rob Truckenmiller, CEO of PharmaCord, talks about the company’s role in patient services, trends he sees shaping patient access to healthcare in the U.S., and a recent patient-centric merger.

As the adoption of biologics rises, demand for home healthcare grows, and conditions like diabetes and autoimmune disorders ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

How the 2028 Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care ...